Established in 1983, CEL-SCI Corporation is a biotechnology company that specializes in the research and development of drugs and vaccines for the treatment of cancer and infectious diseases. The group s core capabilities include drug discovery, research, development and manufacturing of complex biological substances. CEL-SCI Corporation's lead product is Multikine, a product developed for the treatment of cancer. Multikine was developed to help control the power of the immune system against cancer. CEL-SCI Corporation maintains its headquarters in Vienna, Va., the company also has a location in Baltimore. It trades on the American Stock Exchange under the symbol CVM.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.
